Effects of Noscapine and Imatinib on Glioblastoma Cells
Author Information
Author(s): Erguven Mine, Bilir Ayhan, Yazihan Nuray, Ermis Ezgi, Sabanci Akin, Aktas Esin, Aras Yavuz, Alpman Vehbi
Primary Institution: Yeni Yüzyıl University, Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey
Hypothesis
Can the combination of noscapine and imatinib enhance the cytotoxic effects on human glioblastoma cells in vitro?
Conclusion
The combination of noscapine and imatinib showed an antagonist effect in T98G human glioblastoma cells in vitro.
Supporting Evidence
- The combination group induced the highest decrease in cell proliferation and apoptotic indexes.
- Noscapine was shown to reverse P-gp mediated drug resistance.
- Midkine levels were correlated with the antagonist effect observed in the combination treatment.
Takeaway
Researchers tested two drugs, noscapine and imatinib, to see if they could work better together against brain cancer cells, but they found that using them together didn't help as much as expected.
Methodology
The study used monolayer and spheroid cultures of T98G human glioblastoma cells to evaluate the effects of noscapine and imatinib on cell proliferation, apoptosis, and various protein levels over 72 hours.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website